Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Momegalen rich cream and ointment versus vehicle in hand and foot eczema and mild to moderate psoriasis
2008-006148-20Phase 2Completed
- Sponsor
- GALENpharma GmbH
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of mometasone in hand dermatitis, dermatitis and plaque psoriasis (2 arms), sponsored by GALENpharma GmbH. Primary endpoint: Safety and tolerability based on adverse events and serious adverse events. Started Oct 2008; status: completed.
02
Drugs
mometasone
03
Conditions
hand dermatitisdermatitisplaque psoriasis
Beyond the preview
Go deeper on 2008-006148-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006148-20.